Your English writing platform
Discover LudwigSuggestions(5)
Exact(19)
Although the proportion of clients failing ART at 36 months was comparable between those monitored with VL and compared to those monitored with CD4+ cell counts only, the proportion of the clients with multiple resistance mutations especially TAMS was significantly higher in the IM clients.
Insulin dose after 3 months was comparable in both groups (GLA vs. NPH: 23.6 ± 13.4 vs. 23.3 ± 12.7; p = NS ).
Progression-free survival at 9 months was comparable between nintedanib and sunitinib (43.1% vs 45.2%, respectively; P=0.85).
BPAR at 12 months was comparable in the L (23.9%) and MMF (19.4%) groups but higher in the H (34.5%) and M (31.5%) groups.
The median survival in LD with the high MTV (12.0 ± 1.1 months) and high TLG (12.0 ± 1.3 months) was comparable to that of ED (12.0 ± 0.7 months).
In the placebo-teriparatide group, the median PINP at 24 months was comparable to that of the teriparatide group at 12 months.
Similar(41)
Some studies have shown that the results obtained after treatment over a period of less than 3 months were comparable to those obtained after no treatment at all [75] and others described reduction in drug use when patients remained in treatment for at least one year [76].
The characteristics of the respondents and non-respondents at six months were comparable (data not shown).
The overall survival in the patient group (38%% dead at three months) is comparable to other reports [ 3].
5, 20, 36, 37 On the other hand, our median survival of 40 months is comparable with other data.
Furthermore, the values of the Knee Score in the control group at 12 months were comparable with those observed in the experimental group two months post TKA.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com